Blue Horseshoe Stocks: HTGM, MYDX Reviews & A Lot More

HTG Molecular Diagnostics, Inc. HTGM

We placed HGTM on watch for the first time ever in yesterday’s premarket report, and the stock gave a heck of a solid performance, immediately serving up chances at some respectable single-session gains.

The stock traded in a range from 2.85 up to 4.90 which works out to an intraday spike of 72% It did pull back considerably into the close, but we’re definitely going to let it remain on our watchlist for the time being, as it managed to trade roughly 45X its monthly average volume.



Dolat Ventures, Inc. DOLV

Prior to yesterday’s report, the last time we had mentioned DOLV was back in 2015, so it might as well have been new.

It too made a respectable intraday run as it traded up from a low of .0056 and reached a subsequent high of .00975. That worked out to a 74% intraday pop, although it didn’t occur on much more than the 30-day average volume.


MyDx, Inc. MYDX

This is a play we’ve been tracking pretty closely since the end of 2016, with our observed low on the stock coming in at .001 (Feb.16th).

Most recently we re-tagged it in Wednesday’s premarket report, and from a low of .0077 that day, the stock went on to hit .0129 yesterday, for a two day swing of 68% The total five-week run we’ve witnessed from February’s swing low amounts to 1190%


U.S. Stem Cell, Inc. USRM

Just a quick rundown for those who might not be up to speed on USRM- we initially mentioned it on the morning of February 27th after which we’d watch it run from .014-.0545 (+289%). We then tracked its consolidation down to .0175, and highlighted it again two Wednesday’s ago on the 15th.

On Tuesday, we called USRM a “swing trader’s paradise” as we were updating our readers on its performance, which at that time had shown another 200% jump back to the .05-area. But the party didn’t end there. As of yesterday USRM attained a new high of .07, which equates to an overall run of 400% from our observed low (.014) of less than one month ago.


Snap, Inc. SNAP – Options Recap

We’ve been playing SNAP options like a fiddle recently, first with our bearish idea rocketing up over 200% last Friday, and then yesterday with our bullish idea of, the SNAP Weekly $22-23.50 Calls.

$22 Calls – Range: .55-1.20 – Max Gain: 118%
$22.50 Calls – Range: .30-.85 – Max Gain: 183%
$23 Calls – Range: .15-.50 – Max Gain: 233%
$23.50 Calls – Range: .05-.27 – Max Gain: 440%

We’re going to want to continue watching these SNAP Calls through today’s session, keeping in mind that a break 23.75 would signal the need to roll up our strike price to the $24 level.*
______

FRESH OPTIONS IDEAS:
MU Weekly $29-30.50 Calls* – WDC Weekly $78.50-80 Calls*
______

*Trading weekly options on a Friday is extremely high-risk, so if you’re not an advanced-level trader, don’t even think about it!


Extended Watchlist:
PLSB, VDRM, MMEX, VSTM, SFOR

Blue Horseshoe Stocks: Options Roundup & More

Options Roundup 

All of our earnings-related options ideas from yesterday’s report saw increases during the session, so we want to kick things off today by going over those performances, as well as formulating another fresh idea.

FedEx Corp. FDX- Our idea for FDX was less about the earnings figures themselves which fell short of expectations, and more about the buoyed guidance. The investment community at large felt the same way, and as a result FDX made a really nice intraday run from just above $193, to just below $196. That allowed for our ideas, the FDX Weekly $192.50-200 Calls, to put up the following gains:

$192.50 Calls – Range: 1.86-3.96 – Max Gain: 113%
$195 Calls – Range: .90-2.96 – Max Gain: 218%
$197.50 Calls – Range: .29-2.37 – Max Gain: 717%
_____

Petroleo Brasiliero S.A. (Petrobras) PBR – An analyst upgrade coupled with a solid earnings report led us to signal a range of PBR calls yesterday. We mentioned the fact that we’ve had a ton of success on countless occasions in the past trading options in this play, and our streak kept on going. We offered both an idea for the weeklies as well as a couple with an April expiration for a longer-term play, (Weekly $9 Calls – 04/21 $9.50-10.00 Calls) and we saw notable gains in all of them:

Weekly $9 Calls – Range: .12-.27 – Max Gain: 125%
04/21 $9.50 Calls
– Range: .26-.34- Max Gain: 33%
04/21 $10.00 Calls
– Range: .14-.19 – Max Gain: 36%
_____

Dollar Tree, Inc. DLTR – We also highlighted the DLTR 04/21 $78-80 Calls, and while they did see marginal increases, it was nothing to write home about just yet. That’s why we just wanted to remind our readers that these are longer-term idea which could take some time to show us the sort of upward moves we’re looking for.
_____

FRESH IDEA:

Snap, Inc. SNAP – Our bearish signal on SNAP Friday led to success in the SNAP Weekly $20 Puts that we were watching. They gained 246% intraday running from .30-1.04.

Today, we want to reverse our strategy and go with some calls, the SNAP Weekly $22-23.50 Calls to be exact.


Moleculin Biotech, Inc. MBRX

We had MBRX in our extended watchlist yesterday, and were pleased with its solid performance on the day. The stock ran from 1.15 to a high of 1.51, which works out to a respectable intraday increase of 31% The move came on immense volume of more than 40X the 30-day average, so we’ll definitely be interested in continuing to track MBRX as we head into the end of the week.


Extended Watchlist:
DOLV, MCOA, CGIX, PENN, FEYE, HTGM, ZSAN

Blue Horseshoe Stocks: Options Recap & More

Updates on Yesterday’s Options Ideas

Both of our options ideas from yesterday’s premarket report returned some excellent chances for quick intraday profits. While it’s true that we signal Puts very rarely,  that didn’t stop us from sniffing out winning contracts!  

Macy’s, Inc. M –  After releasing disappointing sales figures for Q3 and gapping down considerably in premarket trading, Macy’s continued to plunge, registering a new 52-week low and creating all sort of opportunities within our targeted range, the M Weekly $47-43 Puts.

We had the $43’s run from 1.10-3.33; a move of 203%, and the $44’s turned in an even more impressive performance, shooting up 424% from .85-4.45. At the other end of the spectrum, the $47 Puts popped from 4.46 to 7.00 (+57%), but keep in mind that there were several sets of contracts in between, and traders were faced with potential gains regardless of the increment chosen!

____

Horizon Pharma plc HZNP – HZNP was the other play we were bearish on yesterday, looking at the HZNP Weekly $20-17 Puts. Just like the previously mentioned play, we were afforded the chance at gains no matter what strike price we chose within our selected range of contracts, as the stock continued to pull back.

$20 Puts – Daily Range: 1.70-3.00 – Max Gain: 76%
$19 Puts – Daily Range: 1.15-2.20 – Max Gain: 91%
$18 Puts – Daily Range: .90-1.66  – Max Gain: 46%
$17 Puts – Daily Range: .65-1.30  – Max Gain: 100%

___

FRESH OPTIONS IDEA:
JC Penney Company Inc. JCP

JC Penney got beaten back yesterday and looked oversold in our opinion, but the stock seems to be rebounding nicely in early trading today. We’re going to call attention to both a weekly and a longer term set of contracts that we want to monitor going forward. For intraday/week swing trades, we’ll look to JCP Weekly $8.50 Calls, and for an extended-term watch, we’ll go with the JCP 12/11 $9 and 9.50 Calls. We would be remiss if we failed to mention that JCP earnings are slated for release before market open tomorrow so things could get quite interesting, very soon.



Dolat Ventures, Inc. DOLV

We also want to quickly submit the following subpenny play for speculation. DOLV is going to be a bottom-watch play for us as we near week’s end. Indicators suggest a recovery could be in the cards, so we’ll be watching for the recording of higher highs and higher lows off of its recently established bottom.



Extended Watchlist:
BRWC, ZYXI, GACR, MCET